Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Aug 25, 2017 5:29pm

118 Views

Post# 26623539

RE:RE:RE:RE:Share count went from 125,231,526 to 126,481,526

Hi Thor6570;

Unfortunately, the laser division has not generated enough volume to pass the break even, so they are actually part of the cash burn rate for now. Once Theralase has enough capital on hand, the laser division will get the proper attention, and will be able to do what is necessary to prosper.

Thanks;

made2last

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments